
Pharming Group N.V.
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $90,213 | $72,447 | $106,500 | $97,287 |
Gross Profit | 75,668 | 65,803 | 85,400 | 90,216 |
EBITDA | 8,753 | 1,058 | 9,406 | 23,430 |
EBIT | 5,715 | -2,058 | 6,200 | 20,704 |
Net Income | 1,638 | -5,213 | 5,300 | 7,548 |
Net Change In Cash | 90,213 | 72,447 | 106,500 | 97,287 |
Free Cash Flow | -12,765 | 1,714 | 10,438 | 31,956 |
Cash | 158,281 | 53,104 | 146,021 | 112,752 |
Basic Shares | 70,140 | 70,140 | 75,766 | 66,904 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $376,134 | $297,200 | $245,316 | $205,622 |
Gross Profit | 330,634 | 261,801 | 220,104 | 188,060 |
EBITDA | 34,782 | 16,315 | 9,877 | 33,533 |
EBIT | 23,566 | 245 | -6,048 | 20,345 |
Net Income | 2,851 | -11,841 | -10,548 | 13,674 |
Net Change In Cash | 376,134 | 297,200 | 245,316 | 205,622 |
Free Cash Flow | 53,953 | -2,591 | -18,766 | 20,481 |
Cash | 146,021 | 56,893 | 61,741 | 207,342 |
Basic Shares | 71,317 | 68,918 | 65,702 | 84,284 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.02 |
2026-03-31 | -$0.07 |
2025-12-31 | $0.07 |
2025-09-30 | $0.01 |